Profile | GDS4284 / 228531_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 6065.87 | 95 |
GSM687648 | Patient 402 control | 5013.2 | 93 |
GSM687653 | Patient 403 control | 4117.57 | 92 |
GSM687658 | Patient 404 control | 5703.11 | 94 |
GSM687663 | Patient 411 control | 4156.81 | 92 |
GSM687668 | Patient 422 control | 4500.18 | 92 |
GSM687673 | Patient 424 control | 6102.56 | 95 |
GSM687678 | Patient 425 control | 4145.55 | 92 |
GSM687683 | Patient 427 control | 4918.37 | 93 |
GSM687688 | Patient 428 control | 4273.17 | 92 |
GSM687695 | Patient 441 control | 5356.33 | 94 |
GSM687699 | Patient 443 control | 4004.91 | 92 |
GSM687704 | Patient 444 control | 3276.75 | 90 |
GSM687707 | Patient 448 control | 4156.11 | 92 |
GSM687712 | Patient 449 control | 4967.85 | 93 |
GSM687719 | Patient 450 control | 4545.76 | 93 |
GSM687724 | Patient 451 control | 5757.67 | 94 |
GSM687728 | Patient 452 control | 5623.86 | 94 |
GSM687646 | Patient 401 treated 24h | 5059.24 | 93 |
GSM687649 | Patient 402 treated 24h | 5066.89 | 93 |
GSM687665 | Patient 411 treated 24h | 4419.77 | 92 |
GSM687651 | Patient 402 treated 4 weeks | 4738.08 | 93 |
GSM687667 | Patient 411 treated 4 weeks | 4901.81 | 93 |
GSM687670 | Patient 422 treated 24h | 4265.35 | 92 |
GSM687671 | Patient 422 treated 4 weeks | 4260.12 | 92 |
GSM687654 | Patient 403 treated 24h | 4600.22 | 93 |
GSM687675 | Patient 424 treated 24h | 5745.73 | 94 |
GSM687685 | Patient 427 treated 24h | 4107.29 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 4343.95 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 6441.87 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 4957.16 | 93 |
GSM687692 | Patient 428 treated 4h | 4524.69 | 92 |
GSM687716 | Patient 449 treated 4h | 4554.64 | 92 |
GSM687722 | Patient 450 treated 4h | 5194.65 | 94 |
GSM687680 | Patient 425 treated 24h | 4129.08 | 92 |
GSM687690 | Patient 428 treated 24h | 5621.95 | 94 |
GSM687700 | Patient 443 treated 24h | 4582.48 | 93 |
GSM687705 | Patient 444 treated 24h | 3471.5 | 90 |
GSM687714 | Patient 449 treated 24h | 5462.65 | 94 |
GSM687721 | Patient 450 treated 24h | 5194.66 | 94 |
GSM687682 | Patient 425 treated 4 weeks | 4917.06 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 4937.19 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 4529.83 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 5219.94 | 94 |
GSM687723 | Patient 450 treated 4 weeks | 4968.71 | 93 |
GSM687661 | Patient 404 treated 4h | 6488.47 | 95 |
GSM687710 | Patient 448 treated 4h | 4114.43 | 92 |
GSM687726 | Patient 451 treated 4h | 4556.52 | 93 |
GSM687730 | Patient 452 treated 4h | 4937.97 | 94 |
GSM687660 | Patient 404 treated 24h | 14062.9 | 98 |
GSM687697 | Patient 441 treated 24h | 5356.21 | 94 |
GSM687709 | Patient 448 treated 24h | 4384.79 | 92 |
GSM687725 | Patient 451 treated 24h | 5712.5 | 94 |
GSM687729 | Patient 452 treated 24h | 4741.33 | 93 |
GSM687727 | Patient 451 treated 4 weeks | 5311.43 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 6440.52 | 95 |